“New initiative to fund antidepressants research at WashU through the Taylor Foundation”
The recent development of novel, fast acting, and durable antidepressant treatments such as Ketamine, Brexanolone, and Psilocybin has disrupted our view of the neuroscience and treatment of mood disorders. The Rapid Antidepressants Journal Club focuses on the research into the basic and translational science of how these drugs work.
Dr. Charles Zorumski will be talking, mostly about a new initiative to fund antidepressants research at WashU through the Taylor Foundation.
If you like getting money to do great science, you should attend!
Below are two papers that have just come out that may be of interest to you.
- Vargas, et al. Psychedelics promote neuroplasticity throughthe activation of intracellular 5-HT2A receptors. Science 379, 700–706 (2023)
- Zanos, et al. NMDA Receptor Activation-Dependent AntidepressantRelevant Behavioral and Synaptic Actions of Ketamine. The Journal of Neuroscience, February 8, 2023 • 43(6):1038–1050
Full schedule, Rapid Antidepressants Journal Club
For inquiries contact Joshua Siegel.